As of 2024-12-15, the EV/EBITDA ratio of U.S. Physical Therapy Inc (USPH) is 17.61. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. USPH's latest enterprise value is 1,435.87 mil USD. USPH's TTM EBITDA according to its financial statements is 81.54 mil USD. Dividing these 2 quantities gives us the above USPH EV/EBITDA ratio.
| Range | Selected | |
| Trailing P/E multiples | 5.2x - 10.5x | 6.5x |
| Forward P/E multiples | 5.6x - 11.1x | 6.4x |
| Fair Price | 26.51 - 55.77 | 32.59 |
| Upside | -71.6% - -40.3% | -65.1% |
| Date | EV/EBITDA |
| 2024-12-13 | 17.61 |
| 2024-12-12 | 17.72 |
| 2024-12-11 | 18.02 |
| 2024-12-10 | 18.13 |
| 2024-12-09 | 18.17 |
| 2024-12-06 | 18.09 |
| 2024-12-05 | 18.38 |
| 2024-12-04 | 18.80 |
| 2024-12-03 | 18.63 |
| 2024-12-02 | 18.70 |
| 2024-11-29 | 18.59 |
| 2024-11-27 | 18.28 |
| 2024-11-26 | 18.56 |
| 2024-11-25 | 18.45 |
| 2024-11-22 | 18.42 |
| 2024-11-21 | 18.25 |
| 2024-11-20 | 17.72 |
| 2024-11-19 | 17.08 |
| 2024-11-18 | 16.96 |
| 2024-11-15 | 16.97 |
| 2024-11-14 | 17.00 |
| 2024-11-13 | 17.31 |
| 2024-11-12 | 17.36 |
| 2024-11-11 | 17.82 |
| 2024-11-08 | 17.91 |
| 2024-11-07 | 17.94 |
| 2024-11-06 | 18.28 |
| 2024-11-05 | 15.59 |
| 2024-11-04 | 15.64 |
| 2024-11-01 | 15.37 |
| 2024-10-31 | 15.15 |
| 2024-10-30 | 15.60 |
| 2024-10-29 | 15.39 |
| 2024-10-28 | 15.43 |
| 2024-10-25 | 15.26 |
| 2024-10-24 | 15.47 |
| 2024-10-23 | 15.54 |
| 2024-10-22 | 15.65 |
| 2024-10-21 | 15.75 |
| 2024-10-18 | 16.00 |
| 2024-10-17 | 15.94 |
| 2024-10-16 | 15.84 |
| 2024-10-15 | 15.54 |
| 2024-10-14 | 15.47 |
| 2024-10-11 | 15.17 |
| 2024-10-10 | 14.66 |
| 2024-10-09 | 14.78 |
| 2024-10-08 | 14.65 |
| 2024-10-07 | 14.84 |
| 2024-10-04 | 15.31 |